Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03752268 · ClinicalTrials.gov registry record · NA
Development of an Intervention to Enhance Cancer Pain Management
A NA study, sponsored by Massachusetts General Hospital.
- Active
- Registry status
- NA
- Development phase
- 150
- Enrollment target
NCT03752268: Active NA study, sponsored by Massachusetts General Hospital.
NCT03752268 is a NA study that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 150 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03752268, a NA study, is active but no longer recruiting, sponsored by Massachusetts General Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
Study Summary
This research study is being done to understand how patients with chronic cancer pain take their long-acting opioid medications, and to develop an intervention to enhance cancer pain management.
Interventions
- BEHAVIORAL Enhancing Cancer Pain Management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2014-04-15 |
| Est. Completion | 2026-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03752268
The ClinicalTrials.gov registry entry for NCT03752268 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Enhancing Cancer Pain Management is the first listed.
NCT03752268 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03752268 about?
NCT03752268 is a clinical study titled "Development of an Intervention to Enhance Cancer Pain Management". This research study is being done to understand how patients with chronic cancer pain take their long-acting opioid medications, and to develop an intervention to enhance cancer pain management.
What is the current status of trial NCT03752268?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2014-04-15. Estimated completion is 2026-11-30.
What interventions are being tested in trial NCT03752268?
The interventions under investigation include: Enhancing Cancer Pain Management (BEHAVIORAL).
Who is sponsoring clinical trial NCT03752268?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.